Literature DB >> 17962002

Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.

Giovanni Gaeta1, Sergio Cuomo, Giovanbattista Capozzi, Maria C Foglia, Silvia Barra, Alfredo Madrid, Vincenzo Stornaiuolo, Maurizio Trevisan.   

Abstract

BACKGROUND AND AIM: Most but not all studies in children, adolescents and young adults with a family history of coronary artery disease have reported an increase in lipoprotein(a) (Lp(a)) concentrations. The aim of this study was to assess if healthy children, adolescents and young adults with a parental history of premature myocardial infarction (PHPMI) have increased Lp(a) levels and are at higher risk of elevated (>30 mg/dl) Lp(a) concentrations. METHODS AND
RESULTS: One hundred fifty healthy children, adolescents and young adults with PHPMI (55% males; age 18+/-6.7 years) and 150 age- (+/-1 year) and gender-matched control subjects participated in the study. Concentrations of total plasma cholesterol, low-density lipoprotein (LDL)-cholesterol, high density lipoprotein (HDL)-cholesterol, apolipoprotein (Apo) A-I and B, triglycerides and Lp(a) were determined after fasting for 14 h. Participants with PHPMI had higher concentrations of LDL-cholesterol (107.9+/-31.1 vs. 99.2+/-28.7 mg/dl, p=0.01), Apo B (89.6+/-26.4 vs. 82.8+/-20.2 mg/dl, p=0.011) and Lp(a) (26.7+/-34.0 vs. 19.2+/-23.2 mg/dl, p=0.012) and lower HDL-cholesterol concentrations (47.9+/-11.3 vs. 50.7+/-13.9 mg/dl, p=0.038) than participants without PHPMI. Thirty percent of PHPMI positive subjects had elevated Lp(a) concentrations vs. 16.7% of PHPMI negative subjects (p=0.009; relative risk 2.14; 95% CI 1.23-3.73). In a conditional logistic regression analysis, Lp(a) concentration was significantly and independently associated with PHPMI.
CONCLUSIONS: Healthy young subjects with PHPMI have increased Lp(a) levels, a higher risk for elevated Lp(a) concentrations within an unfavourable lipid profile.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962002     DOI: 10.1016/j.numecd.2007.03.006

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  6 in total

1.  Lipoprotein (a): Examination of Cardiovascular Risk in a Pediatric Referral Population.

Authors:  Omar Qayum; Noor Alshami; Chizitam F Ibezim; Kimberly J Reid; Janelle R Noel-MacDonnell; Geetha Raghuveer
Journal:  Pediatr Cardiol       Date:  2018-06-13       Impact factor: 1.655

2.  Similar Myocardial Perfusion and Vascular Stiffness in Children and Adolescents with High Lipoprotein (a) Levels, in Comparison with Healthy Controls.

Authors:  Kyriaki Papadopoulou-Legbelou; Areti Triantafyllou; Olga Vampertzi; Nikolaos Koletsos; Stella Douma; Efimia Papadopoulou-Alataki
Journal:  Pulse (Basel)       Date:  2021-09-10

Review 3.  South Asian Cardiovascular Disease & Cancer Risk: Genetics & Pathophysiology.

Authors:  Latha Palaniappan; Arun Garg; Enas Enas; Henrietta Lewis; Sehrish Bari; Martha Gulati; Cristina Flores; Ashish Mathur; Cesar Molina; Jagat Narula; Shahid Rahman; Jennifer Leng; Francesca Gany
Journal:  J Community Health       Date:  2018-12

Review 4.  Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction.

Authors:  Enas A Enas; Basil Varkey; T S Dharmarajan; Guillaume Pare; Vinay K Bahl
Journal:  Indian Heart J       Date:  2019-03-20

5.  Identification of copy number variants defining genomic differences among major human groups.

Authors:  Lluís Armengol; Sergi Villatoro; Juan R González; Lorena Pantano; Manel García-Aragonés; Raquel Rabionet; Mario Cáceres; Xavier Estivill
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

6.  Demographics and Angiographic Findings in Patients under 35 Years of Age with Acute ST Elevation Myocardial Infarction.

Authors:  Seyed Kianoosh Hosseini; Abbas Soleimani; Mojtaba Salarifar; Hamidreza Pourhoseini; Ebrahim Nematipoor; Seyed Hesameddin Abbasi; Ali Abbasi
Journal:  J Tehran Heart Cent       Date:  2011-05-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.